Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Portugal

Innovation Action · Running

ORIGIN ORIGIN - Optimized Routing and Industrial Generation of Ingredients from Nature​

Coordinator
Silicolife SA, Portugal
Runs
1 June 2026 to 31 May 2030
Status
Running
EU funding
€5.5m
Total cost
€6.5m
Partners
7 organisations in 6 countries
Type
Innovation Action
Grant agreement
101289831

What the project is doing

In the project's own words, from its summary on CORDIS.

The ORIGIN project (Optimized Routing and Industrial Generation of Ingredients from Nature) directly addresses the Horizon Europe call HORIZON-CL6-2025-01-CIRCBIO-08: Bioprospecting and optimized production of terrestrial natural products, which seeks innovative, sustainable routes to bio-based ingredients. Current supply chains for high-value natural products; used in nutraceuticals, cosmetics, F&F and Pharmarely heavily on wild harvesting of species such as Rhodiola rosea and Panax ginseng.

This unsustainable practice threatens biodiversity, consumer safety, and the resilience of European industries. Precision fermentation offers a solution, but today’s fragmented, costly, and slow pipelines require up to a decade to deliver a single product. ORIGIN introduces a digitally powered, end-to-end bioproduction platform that radically shortens development cycles and de-risks innovation. Its five core breakthroughs are: (i) AI-powered large-scale digital bioprospecting, leveraging the world’s largest proprietary, Nagoya-compliant metagenomic database (>10 billion sequences, >1M new species); (ii) AI-driven retrosynthesis and host-aware pathway design; (iii) generative AI-guided enzyme engineering; (iv) multi-host rapid prototyping across E. coli, S. cerevisiae, Y. lipolytica, and A. niger.

These are unified by the (v) ORIGIN Co-pilot, a central LLM-based agentic AI serving as an “automated scientist” that integrates data streams across the whole project into a closed-loop Design–Build–Test–Learn cycle. By project completion, ORIGIN will deliver AI-optimized pathway blueprints for 50 molecules, 10 validated microbial strains, and 3molecules demonstrated at pilot scale (30L to 100L), achieving >10 g/L titers and >95% purity.

This will reduce time-to-market from 5–10 years to 2–3 years, cut land use by >90% and GHG emissions by 30–50%, and ensure EU leadership in climate-neutral, biodiversity-friendly bioproduction.

Topics

Who is involved

OrganisationCityCountryRole
Silicolife SABragaPortugalCoordinator
Ecole Polytechnique Federale De LausanneLausanneSwitzerlandParticipant
Danmarks Tekniske UniversitetKongens LyngbyDenmarkParticipant
Agencia Estatal Consejo Superior De Investigaciones CientificasMadridSpainParticipant
Dsm Food Specialties BVDelftNetherlandsParticipant
Universidade Nova De LisboaLisboaPortugalParticipant
Basecamp Research LtdLondonUnited KingdomParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI